Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NOCHY, D.
Right arrow Articles by HILL, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NOCHY, D.
Right arrow Articles by HILL, G.
J Am Soc Nephrol 10:507-518, 1999
© 1999 American Society of Nephrology


REGULAR ARTICLES

The Intrarenal Vascular Lesions Associated with Primary Antiphospholipid Syndrome

DOMINIQUE NOCHY*, ERIC DAUGAS*, DOMINIQUE DROZ{dagger}, HELENE BEAUFILS{ddagger}, JEAN-PIERRE GRÜNFELD{dagger}, JEAN-CHARLES PIETTE{ddagger}, JEAN BARIETY* and GARY HILL*

* Service d'Anatomie Pathologique et Service de Néphrologie et Institut National de la Santé et de la Recherche Médicale (INSERM) U430, Hôpital Broussais, Paris, France
{dagger} Laboratoire de Pathologie Rénale et Service de Néphrologie, Hôpital Necker, Paris, France
{ddagger} INSERM U423 et Service de Médecine Interne, Groupe Hospitalier Pitié-Salpétrière, Paris, France.

Correspondence to Dr. Dominique Nochy, Service d'Anatomie Pathologique, 96 Rue Didot, Hôpital Broussais, 75014 Paris, France. Phone: + 33 1 43 95 92 10; Fax: + 33 1 43 95 92 12; E-mail: edaugas{at}infobiogen.fr

Abstract. Even 10 yr after the identification of the antiphospholipid syndrome (APS), renal involvement in the course of APS is still relatively unrecognized, and is probably underestimated. The association of anticardiolipin antibodies and/or lupus anticoagulant with the development of a vaso-occlusive process involving numerous organs is now confirmed. In a multicenter study, 16 cases of "primary" APS (PAPS) were found and followed for 5 yr or more, all with renal biopsy. In all 16 cases of PAPS, there was a vascular nephropathy characterized by small vessel vaso-occlusive lesions associated with fibrous intimal hyperplasia of interlobular arteries (12 patients), recanalizing thrombi in arteries and arterioles (six patients), and focal cortical atrophy (10 patients). In combination, these led to progressive destruction of the kidney, accelerated by acute glomerular and arteriolar microangiopathy in five patients. Focal cortical atrophy is a distinctive lesion, present in 10 biopsies, and likely represents the histologic and functional renal analogue to the multiple cerebral infarcts detected on imaging studies. The clinical hallmark of this vascular nephropathy in PAPS is systemic hypertension, only variably associated with renal insufficiency, proteinuria, or hematuria. The ensemble of histologic renal lesions defined in this study should aid in the separation of the lesions found in cases of secondary APS, especially systemic lupus erythematosus, into those lesions related to APS and those related to the underlying disease.




This article has been cited by other articles:


Home page
NEJMHome page
C. C. Magee, M. P. Coggins, C. S. Foster, V. V. Muse, and R. B. Colvin
Case 2-2008 -- A 38-Year-Old Woman with Postpartum Visual Loss, Shortness of Breath, and Renal Failure
N. Engl. J. Med., January 17, 2008; 358(3): 275 - 289.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. S. Hill and D. Nochy
Antiphospholipid Syndrome in Systemic Lupus Erythematosus
J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2461 - 2464.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Hamid, K Norgate, D P D'Cruz, M A Khamashta, M Arno, J D Pearson, G Frampton, and J J Murphy
Anti-{beta}2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome
Ann Rheum Dis, August 1, 2007; 66(8): 1000 - 1007.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-X. Chen, Y.-Y. Gu, S.-J. Li, J. Qian, K.-K. Hwang, P. P. Chen, S.-L. Chen, and C.-D. Yang
Some Plasmin-Induced Antibodies Bind to Cardiolipin, Display Lupus Anticoagulant Activity and Induce Fetal Loss in Mice
J. Immunol., April 15, 2007; 178(8): 5351 - 5356.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
L J Jara, G Medina, O Vera-Lastra, and L Barile
The impact of gender on clinical manifestations of primary antiphospholipid syndrome
Lupus, August 1, 2005; 14(8): 607 - 612.
[Abstract] [PDF]


Home page
LupusHome page
J Serelis, M G Tektonidou, and F N Skopouli
A case with epilepsy, cognitive impairment, renal microangiopathy and high titres of anticentromere and anticardiolipin antibodies
Lupus, August 1, 2005; 14(8): 625 - 628.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Bhowmik, V. Dadhwal, A. K. Dinda, R. Handa, and S. C. Dash
Steroid-responsive focal segmental glomerulosclerosis in primary antiphospholipid syndrome with successful pregnancy outcome
Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1726 - 1728.
[Full Text] [PDF]


Home page
LupusHome page
E J Lewis and M M Schwartz
Pathology of lupus nephritis
Lupus, January 1, 2005; 14(1): 31 - 38.
[Abstract] [PDF]


Home page
LupusHome page
D P D'Cruz
Renal manifestations of the antiphospholipid syndrome
Lupus, January 1, 2005; 14(1): 45 - 48.
[Abstract] [PDF]


Home page
LupusHome page
M-C Amigo
Coagulopathies and the kidney
Lupus, October 1, 2004; 13(10): 765 - 768.
[PDF]


Home page
LupusHome page
C Rollino, R Boero, F Elia, B Montaruli, C Massara, G Beltrame, M Ferro, G Quattrocchio, and F Quarello
Antiphospholipid antibodies and hypertension
Lupus, October 1, 2004; 13(10): 769 - 772.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
G Espinosa, S Bucciarelli, R Cervera, M Lozano, J-C Reverter, G de la Red, V Gil, M Ingelmo, J Font, and R A Asherson
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies
Ann Rheum Dis, June 1, 2004; 63(6): 730 - 736.
[Abstract] [Full Text]


Home page
LupusHome page
C Korkmaz, S Kabukcuoglu, S Isiksoy, and A U Yalcin
Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy
Lupus, October 1, 2003; 12(10): 760 - 765.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
S R Sangle, D P D'Cruz, W Jan, M Y Karim, M A Khamashta, I C Abbs, and G R V Hughes
Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension
Ann Rheum Dis, October 1, 2003; 62(10): 999 - 1002.
[Abstract] [Full Text]


Home page
Rheumatology (Oxford)Home page
N. A. Dayal and D. A. Isenberg
Endstage renal failure in primary antiphospholipid syndrome--case report and review of literature
Rheumatology, September 1, 2003; 42(9): 1128 - 1129.
[Full Text] [PDF]


Home page
LupusHome page
S Sangle, D D'Cruz, M Khamashta, M F Tungekar, I Abbs, and G Hughes
Goldblatt's kidney, Hughes syndrome and hypertension
Lupus, November 1, 2002; 11(11): 699 - 703.
[PDF]


Home page
LupusHome page
M Y Karim, P Alba, M F Tungekar, I C Abbs, M A Khamashta, G. Hughes, and B J Hunt
Hypertension as the presenting feature of the antiphospholipid syndrome
Lupus, April 1, 2002; 11(4): 253 - 256.
[Abstract] [PDF]


Home page
NEJMHome page
J. S. Levine, D. W. Branch, and J. Rauch
The Antiphospholipid Syndrome
N. Engl. J. Med., March 7, 2002; 346(10): 752 - 763.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Daugas, D. Nochy, D. L. T. Huong, P. Duhaut, H. Beaufils, V. Caudwell, J. Bariety, J.-C. Piette, and G. Hill
Antiphospholipid Syndrome Nephropathy in Systemic Lupus Erythematosus
J. Am. Soc. Nephrol., January 1, 2002; 13(1): 42 - 52.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP